Young Adults Who Inject Drugs at Risk for Hepatitis C Virus

Young adults aged 18-29 years old who live in rural areas and self-report injection drug use are at risk for hepatitis C virus (HCV) infection.  Researchers in New Mexico identified gaps in knowledge about risk and prevention, screening, treatment, and reinfection as a source of this risk and highlight the importance of risk reduction counseling by frontline public health providers.  The study was published earlier this year and is now available in the library of the National Institutes of Health.  Click here for the full report.